INTERNATIONAL PATENT: ADVAGENE BIOPHARMA CO., LTD. FILES APPLICATION FOR "MUCOSAL ADMINISTRATION OF DETOXIFIED E. COLI HEAT-OABILE TOXIN FOR ATTENUATING EOSINOPHILS-DRIVEN INFLAMMATION"

GENEVA, April 17 -- ADVAGENE BIOPHARMA CO., LTD. (6f, No. 308, Sec. 1, Neihu Rd., Neihu Dist.Taipei City, Taiwan) filed a patent application (PCT/CN2025/124312) for "MUCOSAL ADMINISTRATION OF DETOXIFIED E. COLI HEAT-OABILE TOXIN FOR ATTENUATING EOSINOPHILS-DRIVEN INFLAMMATION" on Sep 26, 2025. With publication no. WO/2026/077258, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KUO, Han-Pin (6f, No. 308, Sec. 1, Neihu Rd., Neihu Dist.Taipei City, Taiwan), HSU, Yu-Shen (6f, No. 308, Sec. 1, Neihu Rd., Neihu Dist.Taipei City...